Profilo
Augusto Ocana was a Director at CytoCore, Inc. He was also a Director, General Manager & Senior Vice President at C.H.
Werfen, Inc. from 1999 to 2006.
From 2006 to 2018, he was a Director at MEDITE Cancer Diagnostics, Inc.
Precedenti posizioni note di Augusto Ocana
Società | Posizione | Fine |
---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Direttore/Membro del Consiglio | 23/01/2018 |
C.H. Werfen, Inc. | Direttore/Membro del Consiglio | 01/01/2006 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Aziende private | 2 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
C.H. Werfen, Inc. |
- Borsa valori
- Insiders
- Augusto Ocana